Related Experiment Video
Updated: Dec 23, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Anti-hypertensive effect of crocin and hesperidin combination in high-fat diet treated rats
Mahmoud Hashemzaei1, Ramin Rezaee2,3, Mojtaba Nabatzehi1
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, 9861615881 Zabol, Iran.
Insights
Hesperidin (HES) and crocin (CRO) combination therapy shows promise in reducing blood pressure in a rat model of hypertension. This natural compound combination may offer a preventive strategy for hypertension development.
Area of Science:
- Cardiovascular Research
- Natural Product Pharmacology
- Animal Models of Disease
Background:
- Cardiovascular diseases are the leading global cause of mortality.
- Hypertension is a primary risk factor for cardiovascular diseases.
- Medicinal herbs offer a cost-effective alternative with fewer side effects for managing hypertension.
Purpose of the Study:
- To investigate the antihypertensive effects of hesperidin (HES) and crocin (CRO) administered alone and in combination.
- To evaluate these effects in a rat model of high-fat diet (HFD)-induced hypertension.
- To compare the efficacy of HES and CRO with a combined therapeutic approach.
Main Methods:
- Rats were fed a high-fat diet (HFD) for 7 weeks to induce hypertension.
- Experimental groups received HFD with either CRO (20 mg/kg), HES (20 mg/kg), or a combination of CRO + HES (20 + 20 mg/kg).
- Invasive measurements of mean arterial blood pressure (MAP), systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) were conducted via carotid artery cannulation.
Main Results:
- HFD-induced hypertension significantly increased SBP, HR, and MAP compared to controls.
- Combined administration of CRO + HES significantly reduced SBP, HR, and MAP in HFD-treated rats.
- HES alone significantly decreased SBP, but MAP remained unaffected, while DBP was not significantly altered by any treatment.
Conclusions:
- The simultaneous administration of crocin and hesperidin exhibits significant hypotensive effects in a rat model of HFD-induced hypertension.
- These findings suggest that crocin and hesperidin are potential natural products for further investigation as preventive strategies against hypertension.
- Further research is warranted, particularly for individuals with high-normal blood pressure.
Abstract:
Cardiovascular diseases are the leading cause of death worldwide. Hypertension is the most important cause of such conditions. The use of medicinal herbs is of particular importance due to their lower cost and side effects. The aim of the present study was to compare the effect of hesperidin (HES) and crocin (CRO) alone and in combination, on blood pressure in a rat model of high-fat diet (HFD)-induced hypertension, using invasive carotid artery measurements. Animals were randomly assigned to the following groups: control group (received standard chow diet), HFD control group (received HFD containing 32% kcal of fat and 0.1% cholesterol), and three groups of HFD-treated animals that were treated with a single dose of CRO (20 mg/kg), HES (20 mg/kg), or CRO + HES (20 + 20 mg/kg). Except for the control group, rats received HFD for 7 weeks. On day 50, CRO, HES and normal saline were administered intraperitoneally and carotid arteries of the rats were cannulated. Three hours after the carotid artery cannulation, mean arterial blood pressure (MAP), systolic and diastolic blood pressure (SBP and DBP), and heart rate (HR) were measured using an intra-arterial catheter with the use of a Power Lab system. Data was analyzed using SPSS software. Rats that received HFD for 49 days presented a significant increase in SBP, HR and MAP compared to the control group (P<0.001). Whereas, HFD-treated rats of the CRO + HES group showed lower levels of SBP, HR and MAP; however, DBP remained unaffected. HES administration in HFD treated rats resulted in a significant decrease in SBP compared to the HFD control group with no significant differences in MAP. The hypotensive effects of the simultaneous administration of CRO and HES in HFD-hypertensive rats suggest the need for further study of these two natural products as a potential preventive measure against hypertension development, especially in patients with high normal blood pressure.
More Related Videos
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Atherosclerosis III: Management
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Hypertension II: Pathophysiology